Results 71 to 80 of about 355,803 (282)

Reproducibility Probability Estimation and RP-Testing for Some Nonparametric Tests

Entropy, 2016
Several reproducibility probability (RP)-estimators for the binomial, sign, Wilcoxon signed rank and Kendall tests are studied. Their behavior in terms of MSE is investigated, as well as their performances for RP-testing.
Lucio De Capitani, Daniele De Martini
doaj   +1 more source

Nonparametric Strategy Test

The International FLAIRS Conference Proceedings
We present a nonparametric statistical test for determining whether an agent is following a given mixed strategy in a repeated strategic-form game given samples of the agent's play. This involves two components: determining whether the agent's frequencies of pure strategies are sufficiently close to the target frequencies, and determining whether the ...
openaire   +3 more sources

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

Clinical Validation of Plasma p‐217tau in Neurological Diseases

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, Tetsuya Ueda, Seiji Kinoshita, Chikage Uchida, Takashi Sugawara, Kentaro Hashimoto, Kunihiko Ishizawa, Masakuni Amari, Hiroo Kasahara, Yoshio Ikeda, Masamitsu Takatama, Mikio Shoji   +13 more
wiley   +1 more source

Nonparametric Tests for Treatment Effect Heterogeneity [PDF]

A large part of the recent literature on program evaluation has focused on estimation of the average effect of the treatment under assumptions of unconfoundedness or ignorability following the seminal work by Rubin (1974) and Rosenbaum and Rubin (1983 ...
Guido W. Imbens, Oscar A. Mitnik, Richard K. Crump, V. Joseph Hotz   +3 more
core   +3 more sources

STUDYING THE BANDWIDTH EFFECTS IN NON PARAMETRIC K–SAMPLE TESTS ESTUDIO SOBRE LOS EFECTOS DEL PARÁMETRO DE SUAVIZADO EN CONTRASTES NO PARAMÉTRICOS PARA K–MUESTRAS

Revista Colombiana de Estadística, 2008
The election of the smoothing parameter or bandwidth is, probably, the most important concern in the statistical smoothed techniques. The relevance of this parameter, on the obtained results difficult, the use of these methods in statistical inference ...
Martínez-Camblor Pablo
doaj  

Overview of NonParametric Combination-based permutation tests for Multivariate multi-sample problems

Statistica, 2014
In this work we present a review on nonparametric combination-based permutation tests along with SAS macros allowing to deal with two-sample and one-way MANOVA design problems, within NonParametric Combination methodology framework.
Rosa Arboretti Giancristofaro, Chiara Brombin   +1 more
doaj   +1 more source

DETERMINISTIC NONPARAMETRIC MARKET POWER TESTS: AN EMPIRICAL INVESTIGATION [PDF]

A review of recent literature reflects the development of several deterministic nonparametric market power tests. We use Monte Carlo experiments to evaluate the veracity of four monopolistic and four monopsonistic market power tests that use the ...
Noelke, Corinna M., Raper, Kellie Curry
core   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

Annals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold, Krzysztof W. Selmaj, Regina Berkovich, Jeffrey A. Cohen, Giancarlo Comi, Eva K. Havrdová, James K. Sheffield, Hetal Desai, Chun‐Yen Cheng, Jon V. Riolo, Andrew Thorpe, Erik DeBoer, Bruce A. C. Cree   +12 more
wiley   +1 more source

A Nonparametric Efficiency Analysis of California Cotton Ginning Cooperatives

Journal of Agricultural and Resource Economics, 1993
In the spirit of Leamer's commitment to sensitivity analysis, we employ Farrell's nonparametric efficiency methodology and compare our results with those of Sexton, Wilson, and Wann.
Michael R. Caputo, Lori Lynch
doaj   +1 more source